Advisor Group Holdings, Inc. Edgewise Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,064 shares of EWTX stock, worth $27,685. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,064
Previous 898
18.49%
Holding current value
$27,685
Previous $23,000
21.74%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EWTX
# of Institutions
212Shares Held
101MCall Options Held
1.23MPut Options Held
416K-
Orbimed Advisors LLC San Diego, CA15MShares$391 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$232 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$157 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$152 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$144 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.64B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...